Search

everythinglearnresearchcommunity

for

Search:↓

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Ultrasound is a useful, non-invasive tool in dermatology for diagnosing skin conditions and guiding treatments, but it has some limitations.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

New treatments for hair loss may target specific pathways and generate new hair follicles.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Mast cells might contribute to hair loss by causing skin thickening.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Lipid-coated silica nanoparticles penetrate human skin more deeply than bare silica nanoparticles.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Aging causes changes in the scalp that can affect hair growth and lead to older-looking hair in women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Androgens can both increase body hair and cause scalp hair loss.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.